COVID-19 Fibroblast Based Cell Therapy Candidate Shown to Redu...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
HOUSTON, July 22, 2020 /PRNewswire-AsiaNet/ -- -- FibroGenesis Advances Preclinical Data in Preparation for FDA Investigational New Drug SubmissionFibroGenesis announced today new data supporting use of its PneumoBlast(TM) product in the battle against COVID-19. Using the widely ac...
Authors: LATEST ASIANET NEWS RELEASES